首页|期刊导航|中国药房|美国药师主导的医疗过渡期药物管理模式研究及启示

美国药师主导的医疗过渡期药物管理模式研究及启示OA

Study on the medication management in care transitions led by pharmacists in the United States and its implications

中文摘要英文摘要

目的 为我国建立医疗过渡期药物管理模式提供参考和建议.方法 系统梳理美国药师主导的医疗过渡期药物管理模式,总结其服务体系、人员配置、发展瓶颈和效果收益的实践证据,探索形成对我国相关工作的建议.结果与结论 美国医疗过渡期药物管理模式以规范化的流程和精准化的干预措施为特色,聚焦患者跨机构、跨阶段的治疗衔接期,构建药师主导、多学科协同的标准化监护体系.实证研究表明,该模式可显著减少用药差错、降低医疗成本、提升患者满意度.美国医疗过渡期药物管理模式经过多年发展已逐步实现专业化和标准化,我国可借鉴其成功经验并结合具体国情,从角色定位、培养机制、标准化操作体系和跟踪评价考核标准4个维度逐步建立我国药师主导的医疗过渡期药物管理模式,推动药学服务的进一步发展.

OBJECTIVE To provide references and suggestions for the establishment of medication management in care transitions in China.METHODS This study systematically reviewed the medication management in care transitions led by pharmacists in the United States,summarized the clinical practice evidence of its service system,personnel configuration,development bottlenecks and effect benefits,and explored the suggestions for optimizing the work in China.RESULTS&CONCLUSIONS The United States medication management in care transitions is characterized by standardized workflows and precision interventions.It focuses on the treatment continuity period when patients transition across institutions and stages,establishing a pharmacist-led,multidisciplinary collaborative monitoring system.Empirical studies confirm its effectiveness in reducing medication errors,lowering healthcare costs,and improving patient satisfaction.The United States model has achieved professionalization and standardization.Adapting its successful experiences as well as combining our local situation can establish a pharmacist-led medication management framework in care transitions through four key dimensions:role definition,training mechanisms,standardized protocols,and evaluation metrics,and improve the further development of pharmaceutical care services.

刘夏;杨秋娅;章勉

上海泰康申园康复医院药剂科,上海 201620上海泰康申园康复医院药剂科,上海 201620上海泰康申园康复医院内科,上海 201620

医药卫生

医疗过渡期药物管理模式临床药师药学监护

transitions of caremedication managementclinical pharmacistpharmaceutical care

《中国药房》 2026 (1)

11-16,6

上海市安宁疗护科研能力提升项目(No.2023ANLH35)泰康健投青年医学科研启动基金项目(No.2022022,No.2025028)

10.6039/j.issn.1001-0408.2026.01.03

评论